In this episode, we explore key developments in the global life sciences and biotech sectors. Telangana is set to unveil its Next-Generation Life Sciences Policy 2026–2030 at the World Economic Forum, aiming to position itself as a top global life sciences hub. The U.S. biotech sector faces challenges from inconsistent funding and regulations, risking its global leadership. Lilly and NVIDIA announce a $1 billion AI-focused co-innovation lab in South San Francisco, while Illumina launches the Billion Cell Atlas to enhance AI-driven drug discovery. Hippocratic AI acquires Grove AI to boost its life sciences capabilities. Changes to the UK's Voluntary Pricing and Access Scheme are underway following a UK-US trade deal. Lastly, Rosanna Zhang from ACROBiosystems discusses the use of organoids in neuroscience research, offering new insights into brain disorders.

Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture.

As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics.

Start your VoiceStream free trial today!

📚 Sources:

• https://www.metroindia.net/news/articlenews/telangana-to-unveil-next-gen-life-sciences-policy-at-davos-34250
• https://www.biospace.com/policy/opinion-trump-must-make-biotech-innovation-a-national-priority
• https://www.drugdiscoverytrends.com/lilly-and-nvidia-unveil-1b-co-innovation-lab-in-sf/
• https://www.genengnews.com/topics/drug-discovery/ai-and-drug-discovery-get-a-boost-from-illuminas-billion-cell-atlas-release
• https://pharmaphorum.com/news/hippocratic-ai-builds-life-sciences-grove-ai-buy
• https://pharmaphorum.com/market-access/changes-uks-vpag-non-submissions-should-be-key-metric-impact
• https://www.news-medical.net/news/20260114/Disease-responsive-nanoparticles-enable-ghrelin-mRNA-therapy-in-osteoarthritis.aspx